Awarded

Palivizumab stosowany w programie lekowym: Profilaktyka zakażeń wirusem RS (B.40)

Track this recordFree account — get alerted when a contract here runs out.
Contract value
PLN 1,618,594
Bids received
1
Published
26 Aug 2026
Awarded
28 Jul 2026
Contract start
28 Jul 2026
Contract end
29 Jul 2027estimated
Region
Katowicki

More awards from this buyer